WMHIGH SIGNALFINANCIAL10-K

WM dramatically reduced share buybacks by 80% while significantly increasing capital expenditures by 38%, signaling a major shift in capital allocation strategy toward growth investments.

This represents a fundamental pivot from returning cash to shareholders toward aggressive reinvestment in the business, likely driven by the Stericycle acquisition and expansion into healthcare solutions and renewable energy initiatives. The substantial increase in CapEx combined with reduced buybacks suggests management sees compelling growth opportunities that require significant capital deployment.

Comparing 2026-02-09 vs 2025-02-19View on EDGAR →
FINANCIAL ANALYSIS

WM's financial profile shows a company in major investment mode, with CapEx surging 38% to $2.8B while share buybacks plummeted 80% to just $262M, despite operating cash flow growing a healthy 12% to $6.0B. The company burned through half its cash reserves while boosting stockholders' equity 21% to $10.0B and reducing current liabilities 12%, indicating the funding came from strategic financing rather than operational stress. This financial reconfiguration signals management's confidence in high-return growth opportunities, particularly in healthcare solutions and renewable energy, but represents a dramatic departure from previous shareholder-friendly capital allocation.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-79.9%
$1.3B→$262.0M

Buyback activity reduced 79.9% — capital being redeployed elsewhere or cash conservation underway.

Cash & Equivalents
Balance Sheet
-51.4%
$414.0M→$201.0M

Cash declined 51.4% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Capital Expenditure
Cash Flow
+37.8%
$2.0B→$2.8B

Capital expenditure jumped 37.8% — major investment cycle underway; assess returns on deployment.

Stockholders Equity
Balance Sheet
+21.1%
$8.3B→$10.0B

Equity base grew 21.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

SG&A Expense
P&L
+20.2%
$2.3B→$2.7B

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Operating Cash Flow
Cash Flow
+12.1%
$5.4B→$6.0B

Operating cash flow grew 12.1% — strong conversion of earnings to cash, healthy business fundamentals.

Current Liabilities
Balance Sheet
-11.7%
$6.3B→$5.5B

Current liabilities reduced — improved short-term financial position and working capital health.

LANGUAGE CHANGES
NEW — 2026-02-09
PRIOR — 2025-02-19
ADDED
and Canada that produce renewable electricity and renewable natural gas ( RNG ), which is a significant source of fuel that we allocate to our natural gas fleet.
( Stericycle ), our Healthcare Solutions segment provides regulated waste and compliance services ( RWCS ) and secure information destruction ( SID ) services in the U.S., Canada and Western Europe that protect people and brands, promote health and well-being and safeguard the environment.
Additionally, through our Recycling Processing and Sales segment, we are a leading recycler in the U.S.
During 2025, our largest customer represented less than 5% of annual revenues.
We have enabled a people-first, technology-led focus to drive our mission to maximize resource value, while minimizing environmental impact, and sustainability and environmental stewardship is embedded in all that we do.
Furthermore, we continue to evaluate and plan to pursue emerging diversion technologies that may generate additional value.
In addition, we intend to continue to return value to our stockholders through dividend payments and share repurchases.
In December 2025, we announced that our Board of Directors expects to increase the quarterly dividend from $0.825 to $0.945 per share for dividends declared in 2026, which is a 14.5% increase from the quarterly dividends we declared in 2025.
Additionally, given the substantial progress already made on leverage reduction following the Stericycle acquisition, we resumed share repurchases in February 2026.
Our Board of Directors approved up to $3.0 billion in future share repurchases, exclusive of fees, commissions and taxes.
REMOVED
Risk Factors Summary Our business is subject to numerous risks and uncertainties, including those described in Part I, Item 1A.
These risks include the following: Strategy and Operational Risks If we fail to implement our business strategy, our financial performance and our growth could be materially and adversely affected.
We may not realize the strategic benefits and cost synergies anticipated from the Stericycle acquisition.
Our operations must comply with extensive existing regulations, and changes in regulations, including with respect to emerging contaminants, such as PFAS (as defined below), and extended producer responsibility, can restrict or alter our operations, increase our operating costs, increase our tax liabilities, reduce revenues, or require us to make additional capital expenditures.
Our business is subject to operational and safety risks, including the risk of injury to employees and others.
We may be unable to obtain or maintain required permits for our operations or expand existing permitted capacity at our landfills, due to land scarcity, public opposition or otherwise, which can require us to identify disposal alternatives, resulting in decreased revenue and increased costs.
If we are unable to attract, hire or retain key team members and a high-quality workforce, or if our succession planning does not develop an adequate pipeline of future leaders, it could disrupt our business, jeopardize our strategic priorities and result in increased costs, negatively impacting our results of operations.
Increases in our labor costs as a result of labor unions organizing, changes in regulations related to labor unions or increases in employee minimum wages, could adversely affect our future results.
The seasonal nature of our business, severe weather events resulting from climate change and event driven projects cause our results to fluctuate, and prior performance may not be indicative of our future results.
Damage to our reputation and the value of our brand would negatively impact our business.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →